share

1 day ago by SkinDoc

BioCis Pharma Ltd., a privately held drug development company with its headquarters in Turku, Finland, announced positive results from its Phase IIa clinical trial of ProtoCure(TM) emulsion cream, the company’s novel topical drug for dermatology. This double-blind, placebo-controlled study, conducte ...

The Truth About Skin Care - thetruthaboutskincare.com

share

1 day ago by Vee

I woke up Friday morning with huge puffy eyes after a night in tears and dealing with the news that Max didn't qualify for the clinical trial. I think if he had been given the placebo, I would have dealt with it better. I was prepared. I knew there was a 1 in 3 chance it would happen, but I really h ...

The Sweet Life - sweetvee.blogspot.com · Rank: 14,473 · 11 references

share

1 day ago by bharatbookseo

Indian medical tourism income is expected to reach upto Rs 8,000 Crore by 2012 on back of its low cost medical treatment and a vast pool of well-qualified medical professionals. According to Associated Chambers of Commerce and Industry of India (ASSOCHAM), medical tourism's earnings may go upto Rs 8 ...

MyTripleDub.com - mytripledub.com · Rank: 79,432 · 12 references

share

2 days ago by Pulmonary Disease

BOSTON, June 30 (Reuters) - General Electric Co is teaming up with U.S. biotech company Geron Corp to use stem cells to develop products that could give drug developers an early warning of whether new medicines are toxic. The venture Source: www.alertnet.org Osiris Therapeutics Reports Interim Data ...

COPD Now - copdnow.com · 1 reference

share

2 days ago by Pulmonary Disease

BOSTON, June 30 (Reuters) - General Electric Co is teaming up with U.S. biotech company Geron Corp to use stem cells to develop products that could give drug developers an early warning of whether new medicines are toxic. The venture Source: www.alertnet.org Osiris Therapeutics Reports Interim Data ...

COPD Now - copdnow.com · 1 reference

share

3 days ago by Pulmonary Disease

BOSTON, June 30 (Reuters) - General Electric Co is teaming up with U.S. biotech company Geron Corp to use stem cells to develop products that could give drug developers an early warning of whether new medicines are toxic. The venture Source: www.alertnet.orgOsiris Therapeutics Reports Interim Data F ...

COPD Now - copdnow.com · 1 reference

share

3 days ago by Pulmonary Disease

BOSTON, June 30 (Reuters) - General Electric Co is teaming up with U.S. biotech company Geron Corp to use stem cells to develop products that could give drug developers an early warning of whether new medicines are toxic. The venture Source: www.alertnet.orgOsiris Therapeutics Reports Interim Data F ...

COPD Now - copdnow.com · 1 reference

share

3 days ago by Dizzy Dezzi

FDA: Stop-smoking drugs Chantix, Zyban must carry suicide warning The smoking cessation drugs Chantix and Zyban must now carry a boxed warning the strongest type possible about the risk of serious mental health problems, including depression, behavior changes and suicidal thoughts, the Food and Drug ...

I'm Jus' A Lil' ... - dizzydayz.blogspot.com · Rank: 72,873 · 37 references

share

4 days ago by George Koroneos

Image via Wikipedia FDA announced yesterday afternoon that the smoking cessation drugs Chantix ( varenicline) and Zyban (bupropion) must bear black box warnings for serious mental health symptoms, including changes in behavior, hostility, depression, and attempted suicide. In addition to being used ...

PharmExec Blog - blog.pharmexec.com · Rank: 37,504 · 37 references

share

4 days ago by admin

This time tested adage certainly applies to today’s clinical research environment, especially as it relates to patient recruitment and patient enrollment. In 2001, over 85% of completed clinical trials had patient enrollment delays; 34% were delayed for more than 1 month. In 2003, a month-long delay ...

Time is Money! - resolutions-llc.com/blog